openPR Logo
Press release

Uterine Fibroids Market – Global Industry Analysis, Share, Size, Growth, Demand, Top Companies and 2025 Forecast Report

10-05-2018 11:34 AM CET | Health & Medicine

Press release from: MarketReportsOnline

Global Uterine Fibroids Market Forecast to 2025

Global Uterine Fibroids Market Forecast to 2025

The report “Global Uterine Fibroids Drugs Market: Industry Analysis & Outlook (2017-2025)” analyzes the development of this market, with focus on the US and European markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report.

Access the complete report with Table of Contents available @ http://www.marketreportsonline.com/570256.html.

The four major players: AbbVie, Myovant Sciences, Astra Zeneca, and Neurocrine Biosciences are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global uterine fibroids market along with the study of the regional markets.

Fibroids are tumors in the uterus which can vary in sizes depending upon the condition and level. A woman may have one or many fibroids in reproductive organ. It is common for a woman to have multiple fibroid tumors which are non-cancerous in nature. Uterine fibroids are broadly classified into four categories i.e. Subserosal fibroids, Intramural fibroids, Submucosal fibroid, and Pedunculated submucosal fibroid.

Currently, the uterine fibroid market has no definitive FDA approved agents for medical treatment of uterine leiomyomata or uterine fibroids. Gonadotropin-releasing hormone analogues (GnRHa) agents are being used to reduce size of tumor, reduce blood loss and to correct the ensuing iron-deficiency anemia.

Purchase a copy of this “Global Uterine Fibroids Market” report @ http://www.marketreportsonline.com/contacts/purchase.php?name=570256.

The global uterine fibroids drugs market is expected to experience robust growth post the launch of therapeutic drugs, primarily due to increasing patient base, rise in female population, and increasing healthcare expenditure. However, the market growth is hindered by high R&D costs and regulatory warnings.

Key Topics Covered:

1. Market Overview

2. Global Uterine Fibroids Therapeutic Market Analysis

3. Regional Uterine Fibroids Market Analysis

4. Market Dynamics

5. Competitive Landscape

6. Company Profiles

Explore more related pharmaceuticals market report @ http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About Us:
Market Reports Online is a comprehensive online library of more than 100,000 reports, in-depth market research studies on thousands of micro markets and a range of industries. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe. We offer online and offline support services to ensure your research requirements are met on time.

Contact Info:
Name: Hrishikesh Patwardhan
Email: sales@marketreportsonline.com
Organization: MarketReportsOnline
Phone: + 1 888 391 5441

Source URL: http://www.marketreportsonline.com/570256-toc.html.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Uterine Fibroids Market – Global Industry Analysis, Share, Size, Growth, Demand, Top Companies and 2025 Forecast Report here

News-ID: 1283167 • Views:

More Releases from MarketReportsOnline

US Lettuce & Chicory Market Key Players, Exports & Imports, Size, Share, Demands …
The US lettuce and chicory market is forecasted to reach US$5.09 billion in 2026, experiencing growth at a CAGR of 2.62% during the period spanning from 2022 to 2026. Growth in the lettuce and chicory market is supported by factors such as rising population, rising middle class spending, shift towards veganism/ vegetarianism, increasing awareness regarding the health benefit of chicory and rising social media influence. However, the market growth is
Global Breast Biopsy Market - Hologic, Danaher Corporation, Becton, Dickinson & …
The global breast biopsy market is forecasted to reach US$1.75 billion in 2025, experiencing growth at a CAGR of 8.56% for the period spanning 2022-202. Growth in the global breast biopsy market was supported by factors such as increasing prevalence of breast cancer and rising female population aged 65 or above. Growing adoption of liquid biopsy is likely to have a positive impact on the global breast biopsy market. However,
Global Contract Development & Manufacturing Organization Market - Catalent, Inc. …
The global Contract Development & Manufacturing Organization (CDMO) market is estimated to reach US$246.6 billion in 2026, growing at a CAGR of 9.31%, for the period spanning 2022-2026. The factors such as increasing per capita disposable income, increasing global healthcare expenditure, rising aging population, increasing R&D spending, growing number of new drugs, rise in investments and strategic collaborations and growing demand for pharmaceutical products are expected to drive the market.
Korean Gaming Market (Mobile, PC and Console) - Netmarble, Pearl Abyss, NCSoft, …
The Korean gaming market is anticipated to reach US$20.98 billion in 2026, growing at a CAGR of 6.21% during the period spanning 2022-2026. After the U.S., China, and Japan, it is the fourth largest market, accounting for more than 6% of the worldwide gaming industry in 2021. The growth in the market has been driven by factors like rising smartphone penetration, rapid urbanization, rising gaming subscribers' penetration rate, expansion of MMORPGs,

All 5 Releases


More Releases for Uterine

Uterine Manipulator Devices Market Report 2018: Segmentation by Type (Donnez Typ …
Global Uterine Manipulator Devices market research report provides company profile for ConMed, Richard Wolf, Bisinger, Planmeca Oy, Ethicon Endosurgery, Cooper Surgical, Hospiiniz International, C. R. Bard and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018 - Research By Ma …
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides an overview of the Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) pipeline landscape. Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers
Uterine Leiomyoma (Uterine Fibroids) Market: Global Industry Size, Share, Growth …
Latest industry research report on: Global Uterine Leiomyoma Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts. DelveInsight's,Uterine Leiomyoma (Uterine Fibroids)-Global API Manufacturers,Marketed and Phase III Drugs Landscape,2018" report provides comprehensive insights about marketed and Phase III products for Uterine Leiomyoma (Uterine Fibroids) . The report includes information of marketed products including their product description,patent details,forecasted sales till 2020 & API manufacturer details by country. Global API
Uterine Leiomyoma (Uterine Fibroids)-Drugs Analysis, Market Trends and Forecast …
The various complications of uterine leiomyoma such as discomfort and complications such as anemia from heavy blood loss require the early detection and proper medication. Varying environmental factors such as birth control; vitamin D deficiency; obesity; and drinking alcohol, including beer, appear to increase the risk of developing fibroids. To discuss the market insight in-depth, Market Research Hub (MRH) has lately added a research study titled as “Uterine Leiomyoma (Uterine
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2017”. Uterine fibroids are benign tumors that originate in the uterus (womb). Although they are composed of the same smooth muscle fibers as the uterine wall (myometrium), they are much denser than normal myometrium. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1246573 Uterine fibroids are usually round. The most common
Uterine Fibroids Treatment Market: Rising Prevalence of Uterine Fibroids amongst …
The high prevalence of uterine fibroids across the U.S. has created a significant demand for uterine fibroid treatments across the countries. The growing public concern about the occurrence of uterine fibroids, which are also called uterine leiomyoma, have propelled the demand for treatments and solutions to alleviate the pain, excessive bleeding, and pelvic discomfort. According to the report by Transparency Market Research, the U.S. uterine fibroid treatment market is anticipated to